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The thesis entitled “STEREOSELECTIVE SYNTHESIS OF NATURAL 
OCCURRING BIOACTIVE (S)-CLAVULAZINE, THE C31-C39 FRAGMENT OF 
(+)-PHORBOXAZOLES AND DEVELOPMENT OF NEW SYNTHETIC 
METHODOLOGIES” is divided into three chapters. 
 
Chapter I describes the significance of first stereoselective synthesis of (S)-clavulazine, by 
using barbier type reaction and Grubbs’ metathesis.  
Chapter II deals with the efforts carried out for the synthesis of C31-C39 fragment of (+)-
phorboxazole, by using asymmetric dihydroxylation, Birch and ozonolysis.  
Chapter-III divided into two sections i.e Section A and Section B. 
Section A deals the synthesis of biological active Dihydropyrimidinones in the presence of 
L-proline. 
Section B subdivided into two parts i.e Part A and Part B.  
Part A illustrated the Indium(III) Chloride promoted synthesis of 1,5-benzodiazopines. 
Part B deals with Ag3PW12O40 catalyzed synthesis of 1,5-benzodiazopines under solvent 
free conditions. 
 
Chapter I: Stereoselective synthesis of (S)-clavulazine 
 
Nothing is parallel to nature as a synthetic machine in the production of very 
simple molecules to molecules of several thousand kDa with awesome architecture of vast 
diversity. The aforesaid art of organic synthesis, enacted by the living organisms, through a 
compendium of biochemical processes, is often beyond the scope of synthetic laboratory 
feasibility. To date, many research groups have reported a novel polyfunctionalised 
pyrazine type natural product shows cytostatic and cytotoxic activity comparable to 
doxorubicin, another ant-tumor agent currently used in the treatment of malignant 
lymphomas and leukemias. A major challenge in facilitating the clinical development of a 
novel tubulin-interacting was developing an unsymmetrical steroidal pyrazines, 
polypyrazine derivatives and planar polypyrazines, which are highly nitrogen rich 
polymers with a unique arrangement of the heteroaromatic cores. Pyrazine ring systems are 
not widely distributed in marine metabolites and are mostly restricted to a few distinct 
types of structures. A new marine pyrazine congener, (S)-clavulazine (1) was obtained 
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from Okinawan soft coral, clavularia viridis. The (S)-clavulazine (1) [Figure 1] IUPAC 
name is 5H-pyrano(3,4-b)pyrazine-7-methanol, 7,8-dihydro-(7S), is interest in the 
medicinal chemistry. The structure of 1 was determined on the basis of spectral analysis 
and chemical conversion.  
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Figure 1 
 
The absolute configuration of 1 was unambiguously determined by X-ray 
crystallographic analysis on the p-bromobenzoate. The natural pyrazine alkaloids ring was 
stimulated in wide range of biological properties, including anti-tumor, anti-inflammatory, 
anti-bacterial, anti-diabetic, hypnotic, sedative, analgesic, anticonvulsant, anti-tussive and 
several other useful and interesting properties. 
 
In our strategy, the synthesis of the (S)-clavulazine started with a readily available 
D-mannitol (2), which was converted into 1,2:5,6-di-O-isopropylidene-D-mannitol (3) in 
Scheme 1. Treatment of diacetonide-D-mannitol (3) with NaIO4 to afford the (R)-2,3-O-
isopropelydineglyceraldehyde (4) in quantitative yield. 
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Compound 4 was treated with allyl bromide, activated Zn and sat. NH4Cl which 
gives mixture of 5 and 6 in the ratio 9:1 (Scheme 2). This C-allylation reaction was studied 
under various reaction conditions.  
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However, the best results were obtained when Zinc reagent were reacted in 
tetrahydrofuran at 0 oC to give 9:1 diastereomeric mixture of secondery alcohols 5 and 6, 
easily separated by silica gel column chromatography. Column chromatography separated 
compound 5 was O-allylated using NaH, allyl bromide in dry THF afforded 6 (Scheme 3). 
Conversion of 6 into the diol 7, in presence of catalytic amount of 2N HCl in THF at 0 oC 
to RT. 
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The Diol 7 was treated with sodium metaperiodate (NaIO4) and sat. NaHCO3 in 
DCM at 0 oC to afford aldehyde 8. Subsequently, the resulting aldehyde 8 was subjected to 
reduction with sodium borohydride (NaBH4) in methanol at 0 oC to obtain the 
corresponding alcohol 9. Thus the primary hydroxyl group compound 9 was protected as 
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its methoxy methyl ether using chloromethyl methyl ether, N,N-diisopropylethylamine and 
tetrabutylammonium iodide afforded protected alcohol 10. 
 
Scheme 4
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Now with the required diene in hand, our next endeavor was concentrated towards 
ring closing metathesis reaction on 10 (Scheme 4). With the required diene 10 in hand, 
RCM reaction has been carried out using commercially available Grubbs’ 1st generation 
catalyst in CH2Cl2 at room temperature to obtain 3,6-dihydropyran-2-methanol (11) 
(scheme 4). 
 
Scheme 5
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The accomplished compound 11 reacts with m-CPBA at 0 oC to furnish 
regioisomers 12 and 13 in the ration 60:40 (Scheme 5). Thus, the next concern was the 
synthetic sequence to prepare the azidoalcohol 14, the mixture of regioisomeric 
compounds 12 and 13 was treated with NaN3 in Ethanol: H2O (3:1) at 80 oC to afforded 
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azidoalcohol 14. Obtained compound 14 was subjected to protection reaction using 
methane sulfonyl chloride (MsCl) in DCM at 0 oC to furnish mesylated compound 15 
(Scheme 5). 
 
Scheme 6
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Further proceed for next reaction with mesylated compound 15, which reacted with 
NaN3 in dry DMF at 100 oC for overnight to afforded vicinal diazo compound 16 (Scheme 
6). The vicinal diazide 16 was reduced with Pd/C and pressured H2 in Ethanol at room 
temperature to form the reduced compound 17.  
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The obtained compound 17 was used for the next step without any further 
purification, which was condensed with 40 % glyoxal and 4 Å molecular sieves in EtOH at 
80 oC to give diamine condensed compound 18. Further proceed the next reaction with 
crude compound 18 was aromatization with DDQ in Toluene at 80 oC to afford 19. Finally, 
obtained crude compound 19 was treated with 2N HCl in THF to furnish compound 1 
(Scheme 7). This further, purified through silica gel column chromatography using ethyl 
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acetate-hexane (6:4), in for 3 steps 15% yield. This culminated in the first total synthesis of 
bioactive natural product (S)-clavulazine (1). The analytical and spectral data obtained for 
1 were in complete agreement with reported data. 
 
We have executed the first total synthesis of the natural product (S)-clavulazine. 
The highlights of the synthesis include the installation of the single chiral centre of the 
molecule through diastereoselective Barbier reaction, the construction of dihydropyran ring 
through ring closing metathesis. 
 
Chapter II: Stereoselective synthesis of C31-39 fragment of (+)-Phorboxazoles, 
a natural product from marine Phorbas sp. 
 
Phorboxazole A (1) and its C-13 epimer phorboxazole B (2) [Figure 1] are unique 
oxane-oxazole-based macrolides had been isolated by Molinski and co-workers from 
marine sponge Phorbas sp. and Raspailia sp. found in the Indian Ocean. Apart from 
interesting biological profile of phorboxazoles, the marine natural product also has an 
architecturally challenging structure. The phorboxazole skeleton consists of seven rings 
including two 2,4-disubstituted oxazoles- and 15 stereogenic centers organized into a 
marcrolide (C1-C26) and a side-chain substructure (C27-C46). Phorboxazole A and 
Phorboxazole B differ only in the absolute configuration at C-13. 
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Figure 1 
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These scarce natural compounds show exceptional cytostatic activity against the 
entire panel of human cancer cell lines and antifungal activity against Candida albicans 
but no antibacterial activity against E.coli, Pseudomonas aeruginosa, and Staphylococcus 
aureus. Impressive biological activity coupled with structural complexity made 
phorboxazoles molecule attractive synthetic targets within the chemistry community. 
Phorboxazole A induced cell cycle arrest in the S phase in Burkitt lymphoma cells and 
showed neither inhibition of tubulin polymerization nor interference with the microtubules. 
 
In our strategy, the synthesis started with a readily available m-anisaldehyde (4) 
which was converted into α,β-unsaturated ethyl ester (5) using phosphorous ylide in dry 
toluene reflux at 80 oC. In the Wittig reaction, an aldehyde or ketone is treated with a 
phosphorous ylide to give an olefin. Phosphorus ylides are usually prepared by treatment 
of a phosphonium salt with a base, and phosphonium salts are usually prepared from the 
phosphine and an alkyl halide (Scheme 1). 
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The next endeavour was the preparation of α,β-unsaturated alcohol 6 and hence a 
solution of unsaturated ester 5 in anhydrous CH2Cl2 was added DIBAL in toluene at –78 
oC, thus reaction mixture was allowed to room temperature to give the required product 6. 
The allyl alcohol 6 in anhydrous ether was added a solution of PBr3 in anhydrous diethyl 
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ether was added via syringe dropwise at 0 oC. The resulting mixture was stirred for 1 h 
afforded the allyl bromide (Scheme 1). 
 
In scheme 2, subsequently, the bromo compound 7 was dissolve in acetone, 
heptane (1:1) was added propargyl alcohol at ambient temperature to furnish 8. The 
propargyl alcohol 8 was subjected to protection with dihydropyran and catalytic amount of 
PTSA in anhydrous THF under nitrogen atmosphere at room temperature afforded to THP 
compound 9. 
 
Scheme 2
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Accordingly (Scheme 3), the THP protected derivative 9 was subjected to 
Sharpless Asymmetric Dihydroxylation process using AD-mix-β in t-butanol-H2O to 
obtain enantioselective diol 10. 
 
Scheme 3
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In the Scheme 4, methylation on compound 10 with NaH in Dry DMF at 0 oC 
followed by addition of MeI afforded the methyl protected derivative 11. To convert 
methoxy derivative compound 11, it was treated with catalytic amount of PTSA in DCM at 
room temperature to afford propargyl alcohol. 
 
Scheme 4
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According to Scheme 5, the compound 12 was subjected to reduction of propargyl 
alcohol to allyl alcohol 13 using LAH in THF in 68% yield. The allyl alcohol 13 was 
treated with tert-butyldimethylsilyl chloride and imidazole in tetrahydrofuran at 0 oC to 
give TBS ether derivative 14.  
 
Scheme 5
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In the Scheme 6, the TBS ether derivative 14 was subjected to Sharpless 
Asymmetric Dihydroxylation process using AD-mix-β in t-butanol-H2O to obtain 
enantioselective diol 15. The diol compound 15 was subjected to reaction with 2,2-DMP 
and catalytic PTSA in Dry DCM to give isopropylidene derivative 16. 
 
In the birch reduction (Scheme 7) of compound 16 subjected to reaction using 
Li/Liq NH3 in t-butanol afford 2,5 dihydro compound 17, in this benzylic methoxy group 
knocked out by birch reduction. We recognized solvent system was leading the reaction for 
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knock out the benzylic methoxy group. Tetrahydrofuran as a solvent the reaction was 
observed two methoxy groups was reduced, in isopropanol solvent reduced two methoxy 
groups and diisopropanol solvent system shows same results. 
 
Scheme 6
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In Scheme 7, further we go for next reaction with crude dihydro compound 17 was 
ozonolysis in DCM for 1 h at –78 oC afforded β-ketoester 18 and then crude ozolytic 
compound 18 treated with PPTS in methanol for 3 h to furnish enantioselective compound 
3, which was purified by column chromatograph using methanol and chloroform. 
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In conclusion, we have developed an efficient and highly stereoselective synthesis 
of the C31-C39 fragment of (+)-phorboxazoles through a different synthetic route using 
asymmetric dihydroxylation and a Birch reduction, ozonolyis sequence for generating the 
3,5-disubstituted 5,6-dihydropyran unit. The use of m-anisaldehyde as a masked β-
ketoester is advantageous with an overall yield of 20%. 
 
Chapter III:  
Development of new synthetic methodologies is an important subject in organic 
chemistry. Synthesis involves expensive reagents and catalysts, which are not easily 
available. To replace all such reagents and catalysts different improved processes have 
now been discovered to carry out the reactions efficiently and conveniently with readily 
available inexpensive materials. Modern methodologies are also concerned with the yield 
and selectivity of the products. This chapter subdivided into two sections i.e Section A and 
Section B. 
 
Section A: One-pot synthesis of 3,4-dihydroppyrimidin-2(1H)-ones under 
solvent free conditions. 
 
4-Aryl-3,4-dihydropyrimidinones have recently received great attention because of 
their wide range of therapeutic and pharmacological properties, such as antiviral, anti-
tumor, antibacterial and anti-inflammatory behavior. The DHPMs exhibit a similar 
pharmacological profile to dihydropyridine calcium channel modulators, as novel cell-
permeable molecule, that blocks normal bipolar mitotic spindle assembly in mammalian 
cell and therefore, causes cell cycle arrest, such as hypertension, cardiac arrhythmias or 
angina, as a novel cell-permeable molecule, that blocks normal bipolar mitotic spindle 
assembly in mammalian cells and therefore, causes cell cycle arrest. The DHP calcium 
channel blocker was shown to be a potent against of the α1a-receptor subtype. Multi 
Component Reactions are of increasing importance in organic and medicinal chemistry. In 
such reactions, three or more reactants come together in a single reaction vessel to form 
new products that contain portions of all the components. The three component (2, 3 and 4) 
condensation reactions proceeded smoothly in solvent free at ambient temperature was also 
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completed with in 4-6 hours. Aromatic aldehydes carrying either electron donating of 
withdrawing substituents afforded high yields of products (1) in high purity (Scheme 1). 
 
Scheme 1
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The obtained products in each reaction, the structure of which was established by 
1H, 13C and mass spectroscopy. The scope and generality of this process is illustrated by 
reacting the substrates bearing electron donating as well as electron withdrawing groups in 
aromatic ring. 
 
Section B: Synthesis of 2,3-Dihydro-1H-1,5-benzodiazepine. 
 
2,3-Dihydro-1H-1,5-benzodiazepine derivatives using new methodology. The 
importance of 1,5-benzodizepines, as biologically active compounds comprises their use as 
anticonvulsant, antianxiety, hyponotic agents, inflammatory agents, and in addition, these 
are used as starting materials for the preparation of fused ring compounds such as triazolo, 
oxadiazolo, oxazino or furano-benzodiazepines. Despite their wide of pharmacological 
activity, industrial and synthetic applications, comparatively few methods for their 
preparations are reported in the literature and many of them appeared recently. However 
many of these methods suffer from draw backs, such as drastic reaction conditions, 
cumbersome workup procedures, low yields and co-occurrence of several side reactions. 
This section is subdivided into two Parts i.e Part A and Part B. 
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Part A: Indium (III) bromide: A novel and efficient reagent for the rapid 
synthesis of 1,5-benzodiazepines under solvent- free conditions. 
 
In view of the recent surge in the activity of indium reagents as mild and water-
tolerant Lewis acids, we wish to disclose a novel protocol for the rapid synthesis of a 
variety of biologically significant 1,5-benzodiazepines using a catalytic amount of 
indium(III) bromide under extremely mild conditions. For instance, treatment of o-
phenylenediamine with acetone in the presence of 10 mol % indium(III) bromide for 1.5 h 
afforded 2,3-Dihydro-2,2,4-trimethyl-1H-1,5-bnzo[b][1,4]diazapine (3 and 5) in 95% 
yield.  
 
Scheme 1
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Similarly, various ketones such as acetophenone, 2-butanone, isobutylmethylketone 
and 3-pentanone reacted smoothly with o-phenylenediamine under similar reaction 
conditions to give the corresponding 1,5-benzodiazepines in 79-96 % yields (Scheme 1).  
 
Part B: Ag3PW12O4: A novel and recyclable heteropoly acid for the synthesis of 
1,5-benzodiazepines under solvent free conditions. 
 
The use of solid acids as heterogeneous catalysts has received considerable interest 
in different areas of organic synthesis. Heterogeneous solid acids are advantageous acid 
conventional heterogeneous acid catalyst as they can be easily recovery from the reaction 
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mixture by simple filtration and can be reused after activation or without activation, 
thereby making the process economically viable. Among various heterogeneous catalyst, 
heteropoly acids are most attractive. In view of the emerging importance of the use of 
heterogeneous solid acids as reused in organic synthesis, here in this section, we wish to 
disclose a mild and efficient protocol for the synthesis of 1,5-benzodiazepines using a 
silver salt of heteropoly acid (Ag3PW12O40) as a novel heterogeneous catalyst. 
 
Scheme 2
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According to Scheme 2, treatment of o-phenylenediamine with acetone in the 
presence of silver salt of 12-tungustuphosphoric acid (Ag3PW12O40) at room temperature 
afforded 2,4,4-trimethyl-2,3-dihydro-1H-1,5-benzodiazepines in 92% yield. Similarly, 
various ketones such as acetone, acetophenone, 2-butanone, and isobutyl methyl ketone 
underwent smooth condensation with o-phenylenediamines in solvent-free conditions to 
give the corresponding 1,5-benzodiazepines in 80-95% yields. The reactions were clean 
and products were obtained in high yields in short reaction times. The crude products were 
purified either by recrystallization from a mixture of Et2O-n-hexane or by silica gel column 
chromatography. The reaction of cyclic ketones such as cyclohexanone, cyclopentanone, 
and cycloheptanone with o-phenylenediamine in the presence of Ag3PW12O40 afforded 
fused ring 1,5- benzodiazepines in good yields. 
